A patient presents with agitation, tremors, and anxiety after missing benzodiazepine doses. Which statement best reflects appropriate next steps?

Study for the BIPC Substance Abuse and Disorders Exam. Challenge yourself with a variety of questions to enhance your knowledge and strengthen your preparation. Each question comes with hints and explanations to help you understand and retain crucial information.

Multiple Choice

A patient presents with agitation, tremors, and anxiety after missing benzodiazepine doses. Which statement best reflects appropriate next steps?

Explanation:
Benzodiazepine withdrawal can be dangerous, with risk of seizures and other serious complications if not managed in a controlled setting. When a patient presents with agitation, tremors, and anxiety after missing doses, it signals clinically significant withdrawal that benefits from medical supervision and a structured taper. Inpatient detoxification provides continuous monitoring, the ability to start a supervised taper using a long-acting benzodiazepine, and rapid management of any escalating symptoms or complications. This approach helps safely reduce dependence while preventing withdrawal-related harm and supports the patient in transitioning to a planned, longer-term taper or stabilization plan. Refilling the same prescription would not address the withdrawal risks and could perpetuate dependence. An outpatient taper is possible in milder cases or with strong support and stability, but the current symptoms point to a scenario where inpatient management offers the safest, most effective monitoring and dosing. Prescribing barbiturates to ease withdrawal is not appropriate due to safety concerns and the risk of new dependence; they are not the preferred method for managing benzodiazepine withdrawal.

Benzodiazepine withdrawal can be dangerous, with risk of seizures and other serious complications if not managed in a controlled setting. When a patient presents with agitation, tremors, and anxiety after missing doses, it signals clinically significant withdrawal that benefits from medical supervision and a structured taper. Inpatient detoxification provides continuous monitoring, the ability to start a supervised taper using a long-acting benzodiazepine, and rapid management of any escalating symptoms or complications. This approach helps safely reduce dependence while preventing withdrawal-related harm and supports the patient in transitioning to a planned, longer-term taper or stabilization plan.

Refilling the same prescription would not address the withdrawal risks and could perpetuate dependence. An outpatient taper is possible in milder cases or with strong support and stability, but the current symptoms point to a scenario where inpatient management offers the safest, most effective monitoring and dosing. Prescribing barbiturates to ease withdrawal is not appropriate due to safety concerns and the risk of new dependence; they are not the preferred method for managing benzodiazepine withdrawal.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy